Having served patient health for 33 years, Salospir by UNI-PHARMA was honored with the “Centennial Brand 2019” distinction at an event organized by The Business Review economic magazine, under the auspices of SEV (Hellenic Federation of Enterprises), ACCI (Athens Chamber of Commerce and Industry), and SELPE (Hellenic Retail Business Association). The award was presented by the President of the Athens Chamber of Commerce and Industry, Konstantinos Michalos, and received by UNI-PHARMA’s Marketing Manager, Markos Theodorou.

Salospir has been a product of UNI-PHARMA’s research and expertise since its launch in 1986. It contains acetylsalicylic acid in the form of enteric-coated tablets. According to clinical studies, it provides essential preventive therapy as an antithrombotic and platelet aggregation inhibitor.
In 2018, Salospir reached 10 million units in sales in Greece alone, achieving over 3% growth compared to the previous year.